A NEW ONCOLYTIC VIRUS PLATFORM TO TREAT CANCERS WITH MYXOMA VIRUS

Disclosed herein, in certain embodiments, are recombinant myxoma viruses (MYXVs) and nucleic acid constructs encoding the recombinant MYXVs. In some embodiments, the MYXVs are engineered to inactivate or attenuate an activity or expression level of an M153 protein. In some embodiments, the MYXVs are...

Full description

Saved in:
Bibliographic Details
Main Authors MCFADDEN, Douglas Grant, FRANCO ACHURY, Lina, SHARP, Leslie Lynne, VILLA, Nancy, RAHMAN, Mohammed Masmudur, TORRES-DOMINGUEZ, Lino
Format Patent
LanguageEnglish
French
Published 11.03.2021
Subjects
Online AccessGet full text

Cover

Loading…